Top Markets
#1 DogBull DogBull +108.55%
#2 MarsCoin MarsCoin +76.65%
#3 Siacoin Siacoin +56.43%
#4 ADO Protocol ADO Protocol +52.50%
#5 Ontology Gas Ontology Gas +32.10%
#6 The Bitcoin Bull The Bitcoin Bull +30.29%
#7 Apertum Apertum +16.15%
#8 Pons Pons +13.49%
#9 Useless Coin Useless Coin +12.60%
#10 Stratis Stratis +12.32%
Coin of the day
DogBull DogBull
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. Common Stock

LXEO
Classifica tra le azioni #15117
Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical... Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features several gene therapy candidates. These include LX2006, an AAVrh10-based therapy aimed at treating cardiomyopathy linked to Friedreich's ataxia (FA); LX2020, another AAVrh10-based candidate targeting arrhythmogenic cardiomyopathy; LX2021, designed for DSP cardiomyopathy; and LX2022, which focuses on hypertrophic cardiomyopathy (HCM) stemming from TNNI3 mutations. Furthermore, Lexeo is advancing LX1001, an AAVrh10-based gene therapy, alongside LX1020 and LX1021, all intended for individuals homozygous for APOE4. Additionally, LX1004 is under development to treat CLN2 Batten disease. Established in 2017, the company's headquarters are located in New York, New York.
Prezzo delle azioni
$4.74
Ultima sincronizzazione: 2026-08-31
Capitalizzazione di mercato
$372.19M
Variazione (1 giorno)
-2.47%
Variazione (1 anno)
-1.04%
Paese
US
Scambia Lexeo Therapeutics, Inc. Common Stock (LXEO)

Categoria

Healthcare
Il prezzo LXEO con la capitalizzazione del mercato della B
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
LXEO
$4.74
Capitalizzazione di mercato di Lexeo Therapeutics, Inc. Common Stock(LXEO)
Capitalizzazione di mercato: $372.19M
A partire dal September 2026, Lexeo Therapeutics, Inc. Common Stock ha una capitalizzazione di mercato pari a $372.19M. Questo rende Lexeo Therapeutics, Inc. Common Stock la 15117th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Lexeo Therapeutics, Inc. Common Stock dal 2023 al 2026
LXEO in paragone con la classifica dei più popolari stocks
Il prezzo per LXEO Attivo B Capitalizzazione del mercato a B Risultati
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$67,838.67 $372.19M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.327T +1,431,095.66%
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$59,154.10 $372.19M
Apple Inc. Apple Inc.
AAPL
$4.645T +1,247,876.74%
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$51,836.16 $372.19M
Alphabet Inc. Alphabet Inc.
GOOG
$4.070T +1,093,489.98%
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$48,197.93 $372.19M
Microsoft Corporation Microsoft Corporation
MSFT
$3.785T +1,016,733.97%
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$35,533.17 $372.19M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.790T +749,545.01%